Effects of HMG-CoA Reductase Inhibitor on Experimental Autoimmune Myocarditis

Xiaoman Liu,Bo Li,Wenke Wang,Cheng Zhang,Mingxiang Zhang,Yun Zhang,Yanfei Xia,Zhe Dong,Yuan Guo,Fengshuang An
DOI: https://doi.org/10.1007/s10557-012-6372-6
2012-01-01
Cardiovascular Drugs and Therapy
Abstract:Myocarditis is an acute inflammatory disease of the heart and is often a precursor of dilated cardiomyopathy. Experimental autoimmune myocarditis (EAM) has been used as a model for human myocarditis. The purpose of this study was to investigate the therapeutic role of 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase inhibitor, rosuvastatin, on the development of EAM.
What problem does this paper attempt to address?